Research Article

Meta-Analysis: The Efficacy and Safety of Paricalcitol for the Treatment of Secondary Hyperparathyroidism and Proteinuria in Chronic Kidney Disease

Figure 4

Comparison of the reduction in proteinuria netween the 1 ug/d and 2 ug/d groups.
320560.fig.004